HCPCS Level II
J1566
Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
Codes near J1566
These sit next to J1566 in the CMS Level II file. All J codes
- J1558Injection, immune globulin (xembify), 100 mg
- J1559Injection, immune globulin (hizentra), 100 mg
- J1560Injection, gamma globulin, intramuscular, over 10 cc
- J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562Injection, immune globulin (vivaglobin), 100 mg
- J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1570Injection, ganciclovir sodium, 500 mg
- J1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
- J1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00944-2656-03 | Gammagard S/D | Takeda Pharmaceuticals America, Inc. | 10 |
| 00944-2658-04 | Gammagard S/D | Takeda Pharmaceuticals America, Inc. | 20 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.